Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is atherosclerosis an infectious disease?

S D Mawhorter1, M A Lauer

  • 1Department of Infectious Disease, Cleveland Clinic Foundation, OH 44195, USA. mawhors@ccf.org

Cleveland Clinic Journal of Medicine
|May 16, 2001
PubMed
Summary

Infections like Chlamydia pneumoniae may contribute to atherosclerotic coronary artery disease. However, antibiotic treatment for coronary events is not recommended until clinical trials conclude.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parasitic infections in solid organ transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2009
Same author

Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection.

Transplant infectious disease : an official journal of the Transplantation Society·2003
Same author

The humoral immune response to influenza vaccination in lung transplant patients.

The European respiratory journal·2002
Same author

Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.

Circulation·2001
Same author

Who should receive hepatitis A vaccine?

Cleveland Clinic journal of medicine·2001

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathogenesis of Atherosclerosis

Background:

  • Atherosclerotic coronary artery disease (CAD) is a complex condition with multiple contributing factors.
  • Emerging evidence suggests infectious agents may play a role in the development and progression of CAD.
  • Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus are among the pathogens implicated.

Purpose of the Study:

  • To review the evidence linking specific infections to atherosclerotic coronary artery disease.
  • To discuss the implications of these findings for clinical practice and future research.

Main Methods:

  • Literature review of studies investigating the association between infections and CAD.
  • Analysis of data from clinical trials examining antibiotic interventions for CAD.

Main Results:

  • Chlamydia pneumoniae shows the most substantial evidence implicating infection in CAD.
  • Helicobacter pylori and cytomegalovirus are also considered potential contributing factors.
  • Clinical trials evaluating antibiotic efficacy in reducing coronary events are ongoing.

Conclusions:

  • While infections are implicated in CAD, definitive conclusions regarding antibiotic therapy are pending.
  • Current evidence does not support the routine use of antibiotics to prevent or treat coronary events.
  • Further research and clinical trial results are necessary to guide therapeutic strategies.

Related Experiment Videos